INVU on OTC

Investview, Inc.

Investview, Inc. is an American business services company, incorporated in Nevada.1 It is headquartered in Haverford, Pennsylvania.1 Its shares trade on OTC under the symbol INVU.1

Price unavailable

Last updated Oct 20, 2026.

Overview

Compare with Currenc Group Inc., Datavault AI Inc. or EPWK Holdings Ltd., or pick any stock.

  • TickerINVU on OTC1
  • IndustryServices-Business Services, NEC1
  • HeadquartersHaverford, Pennsylvania1
  • Incorporated inNV2
  • Business address521 W. Lancaster Ave, Floor 2, Haverford, Pa 190412
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-22.8%Operating margin4
-24.6%Net margin4
-30.8%Revenue growth, 20254
-99.9%Return on equity4
-$4.2MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Membership Revenue brought in 40% of the revenue Investview, Inc. broke down this way in fiscal 2025.

  1. Membership Revenue$29.2M440%down 38% from 2024
  2. Foreign Revenue$24.9M434%down 42% from 2024
  3. Domestic Revenue$11.4M416%up 20% from 2024
  4. Health and Wellness Revenue$3.6M45%up 3187% from 2024
  5. Mining Revenue$3.3M45%down 36% from 2024
Products and services by year
Products and services20242025
Membership Revenue$47.1M$29.2M
Foreign Revenue$42.9M$24.9M
Domestic Revenue$9.5M$11.4M
Health and Wellness Revenue$110.7K$3.6M
Mining Revenue$5.2M$3.3M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Other costs100¢$36.2M
  • Income tax0¢$58.8K

Out of $36.3M in revenue.4 The company lost money this year.

Financial statements

Revenue56784$36.3M in 2025+22% since 2019
0$20.0M$40.0M$60.0M$80.0M2019: $29.7M$29.7M20192020: $24.2M$24.2M2020−18%2021: $38.3M$38.3M2021+58%2022: $61.8M$61.8M2022+62%2023: $67.9M$67.9M2023+10%2024: $52.4M$52.4M2024−23%2025: $36.3M$36.3M2025−31%
Operating income56784-$8.3M in 2025+110% since 2019
-$15.0M-$10.0M-$5.0M0$5.0M2019: -$3.9M-$3.9M20192020: -$13.3M-$13.3M2020+238%2021: $774.4K$774.4K20212022: -$8.6M-$8.6M20222023: $4.6M$4.6M20232024: $1.7M$1.7M2024−63%2025: -$8.3M-$8.3M2025
Net income56784-$8.9M in 2025+78% since 2019
-$30.0M-$20.0M-$10.0M0$10.0M2019: -$5.0M-$5.0M20192020: -$21.3M-$21.3M2020+325%2021: $565.8K$565.8K20212022: -$12.9M-$12.9M20222023: $2.8M$2.8M20232024: $1.2M$1.2M2024−58%2025: -$8.9M-$8.9M2025

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Total revenue, net$36.3M$52.4M
Cost of sales and service$8.2M$6.1M
Commissions$16.0M$25.9M
Advertising, selling, and marketing$564.6K$569.5K
Salary and related$7.1M$6.6M
Professional fees$2.3M$1.5M
Impairment expense$903.2K$1.8M
Loss (gain) on disposal of assets-$104.7K$180.2K
General and administrative$9.6M$8.0M
Total operating costs and expenses$44.5M$50.7M
Net income (loss) from operations-$8.3M$1.7M
Gain (loss) on settlement-$111.3K-$375.0K
Gain (loss) on fair value of derivative liability$758$5.0K
Realized gain (loss) on digital assets$120.2K$452.4K
Unrealized gain (loss) on digital assets-$591.1K
Other income (expense)$1.1M$1.6M
Total other income (expense)-$707.2K$390.6K
Income (loss) before income taxes-$9.0M$2.1M
Income tax expense$58.8K-$894.9K
Net income (loss)-$8.9M$1.2M
Net income (loss) attributable to noncontrolling interest$4.5K-$753
Net income (loss) attributable to Investview, Inc.-$8.9M$1.2M
Dividends on Preferred Stock-$819.3K-$819.3K
Net income (loss) applicable to common shareholders-$9.7M$371.8K
Basic income (loss) per common share-$0.01$0.00
Diluted income (loss) per common share-$0.01$0.00
Basic weighted average number of common shares outstanding1.9B shares1.9B shares
Diluted weighted average number of common shares outstanding1.9B shares2.9B shares

Compare Investview, Inc. with another company

Corporate structure

Investview, Inc. sits at the top of its group. 13 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Investview, Inc. Haverford, Pennsylvania
    • AF Enterprise Holdings, LLC Subsidiary · Delaware, United States
    • Conectiv LLC (formerly iGenius, LLC) Subsidiary · Utah, United States
    • ELRT Technologies, LLC Subsidiary · Pennsylvania, United States
    • Goldman’s Pharmaceuticals LLC Subsidiary · Pennsylvania, United States
    • iGenius Global LTD Subsidiary · Ireland
    • Investview Financial Group Holdings, LLC Subsidiary · Delaware, United States
    • Investview MTS, LLC Subsidiary · Delaware, United States
    • myLife Wellness Company Subsidiary · Delaware, United States
    • Opencash Finance, Inc. Subsidiary · Delaware, United States
    • Opencash Securities, LLC Subsidiary · Delaware, United States
    • Renu Laboratories LLC Subsidiary · Delaware, United States
    • SAFETek LLC Subsidiary · Utah, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Investview, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$9.1M4 Dec 31, 2025$13.0M4 Dec 31, 2024−30.0%
Accumulated depreciation$7.5M4 Dec 31, 2025$11.1M4 Dec 31, 2024−33.0%
Property and equipment, net$1.6M4 Dec 31, 2025$1.9M4 Dec 31, 2024−12.1%
Operating-lease assets (leased space)$76.8K4 Dec 31, 2025$212.0K4 Dec 31, 2024−63.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$10.0M4 Dec 31, 2025$22.5M4 Dec 31, 2024−55.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$873.7K4 Dec 31, 2024$123.6K12 Mar 31, 2013+606.9%
Finite-lived intangibles, net$10.8K4 Dec 31, 2025$40.3K4 Dec 31, 2024−73.2%

Inventory

ItemLatestA year beforeChange
Inventory, total$663.0K4 Dec 31, 2025$495.9K4 Dec 31, 2024+33.7%
Raw materials$508.6K4 Dec 31, 2025$467.8K4 Dec 31, 2024+8.7%
Work in process$115.7K4 Dec 31, 2025$3124 Dec 31, 2024+36993.9%
Finished goods$38.7K4 Dec 31, 2025$27.8K4 Dec 31, 2024+39.1%

Properties, in its own words

Our corporate headquarters, consisting of approximately 7,102 square feet of office space is located at 521 West Lancaster Avenue, Second Floor, Haverford, Pennsylvania 19041 and is being leased under a one-year lease agreement that will expire in December 2026. Our Conectiv headquarters consisting of approximately 1,325 square feet of office space is located at 459 North 300 West, #15, Kaysville, Utah 84037 and is on a month-to-month lease. The manufacturing headquarters consisting of approximately 12,500 square feet of office and manufacturing space for Renu Laboratories LLC is located at 1836 Stout Drive, #1, 2, 5, 6, and 7, Warminster, Pennsylvania 18974 and are being leased under a one-year lease that will expire in December 2026. Additionally, approximately 5,686 square feet of warehouse space for Renu Laboratories LLC located at 48 Vincent Circle, #48B, Ivyland, Pennsylvania 18974 is being leased for storage of materials and pre-finished goods under a 2-year lease agreement that will expire in December 2026. We lease administrative office space, which is located at 386 Main Street, #212, Wyckoff, New Jersey 07481, and is being leased under a two-year lease agreement that will expire in July 2027 with an option for the Company to terminate with 60 days’ written notice.

Item 2 of the 10-K filed Mar 31, 2026.13

Leadership

Who has led Investview, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (17)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • AF Enterprise Holdings, LLC Delaware3
  • Conectiv LLC (formerly iGenius, LLC) Utah3
  • ELRT Technologies, LLC Pennsylvania3
  • Goldman’s Pharmaceuticals LLC Pennsylvania3
  • Investview Financial Group Holdings, LLC Delaware3
  • Investview MTS, LLC Delaware3
  • Opencash Finance, Inc. Delaware3
  • Opencash Securities, LLC Delaware3
  • Renu Laboratories LLC Delaware3
  • SAFETek LLC Utah3
  • iGenius Global LTD Ireland3
  • myLife Wellness Company Delaware3
  • myLife Wellness LLC Delaware3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Global Investor Services, Inc.Oct 9, 2008 to Apr 18, 20122
  • Voxpath Holdings, Inc.Jun 28, 2006 to Sep 14, 20062
  • TheRetirementSolution.com, Inc.Jun 9, 2005 to Oct 1, 20082
  • UINTAH MOUNTAIN COPPER COMPANYNov 8, 1999 to May 9, 20062

Timeline

  1. Feb 3, 20268-K Executive or director change; Regulation FD disclosure36
  2. Jan 5, 20268-K Other events37
  3. May 1, 20258-K Other events38
  4. Mar 28, 20258-K Other events39
  5. Mar 5, 20258-K Other events40
  6. Mar 4, 20258-K Entered a material agreement41
  7. Jan 17, 20258-K Other events42
  8. Oct 31, 20248-K Other events43
  9. Sep 30, 20248-K Other events44
  10. Aug 20, 20248-K Executive or director change45
  11. Mar 18, 20248-K Regulation FD disclosure46
  12. Feb 12, 20248-K Entered a material agreement; Regulation FD disclosure47
  13. Apr 11, 2022New chief executive Victor M. Oviedo becomes CEO14
  14. Jan 31, 2020New chief executive Joseph Cammarata becomes CEO15
  15. Jul 26, 2019New chief executive Annette Raynor becomes CEO16
  16. Aug 15, 2017New chief executive Ryan Robins Smith becomes CEO17
  17. Sep 7, 2012New chief executive Joseph J. Louro becomes CEO18
  18. Aug 25, 2010New chief executive Nicholas S. Maturo becomes CEO19

Calendar

When it reported results

  1. Nov 14, 2022Reported quarterly or annual results48

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

68 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 27 major events, 15 insider forms, 5 other. The latest 20:

  1. Aug 14, 202610-Q EDGAR
  2. May 15, 202610-Q EDGAR
  3. Mar 31, 202610-K EDGAR
  4. Feb 3, 20268-K EDGAR
  5. Jan 30, 20264 EDGAR
  6. Jan 30, 20263 EDGAR
  7. Jan 5, 20268-K EDGAR
  8. Nov 13, 202510-Q EDGAR
  9. Aug 13, 202510-Q EDGAR
  10. May 14, 202510-Q EDGAR
  11. May 1, 20258-K EDGAR
  12. Mar 28, 202510-K EDGAR
  13. Mar 28, 20258-K EDGAR
  14. Mar 5, 20258-K EDGAR
  15. Mar 4, 20258-K EDGAR
  16. Jan 17, 20258-K EDGAR
  17. Nov 13, 202410-Q EDGAR
  18. Oct 31, 20248-K EDGAR
  19. Sep 30, 20248-K EDGAR
  20. Aug 20, 20248-K EDGAR

The 68 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Investview, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARInvestview, Inc.1
  • CIK0000862651
  • Employer ID (EIN)87-036920513
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company13
  • Incorporated inNevada13
  • Fiscal year endsDecember 311
  • Industry code (SIC)7389 Services-Business Services, NEC1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address521 W. Lancaster Ave, Floor 2, Haverford, PA 190411
  • Phone732-889-43001
  • Shares outstanding1,844,470,389 as of Aug 7, 202610
  • Public float$19.3M as of Jun 30, 202513
  • AuditorM&K CPAS, PLLC, The Woodlands, TX PCAOB ID 2738; no auditor attestation of internal control over financial reporting13
  • On EDGAR sinceAug 12, 19991
  • Filings562 in all: 8-K (177), 10-Q (55), 4 (52), 3 (28), 10QSB (26), NT 10-Q (25), 10-K (18), 8-K/A (17)1
    All 42 form types

    NT 10-K (15), UPLOAD (15), CORRESP (14), DEF 14C (10), 10KSB (9), D (9), PRE 14C (9), S-1/A (8), SC 13D (8), 4/A (7), EFFECT (7), S-8 (6), SC 13D/A (6), POS AM (5), S-1 (5), 10-K/A (3), 10-Q/A (3), SC 13G (3), SC 14F1 (3), 10SB12G/A (2), 424B3 (2), PRER14C (2), SC 13G/A (2), 10-KT (1), 10KSB/A (1), 10SB12G (1), 3/A (1), 5 (1), D/A (1), REGDEX/A (1), SB-2 (1), SB-2/A (1), SC TO-I (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2026
    Quarterly report (10-Q) Aug 14, 2026
    Latest 8-K (8-K) Feb 3, 2026

Risk factors and legal proceedings

The risks Investview, Inc. names in Item 1A of its 10-K filed Mar 31, 2026: 57 risks under these headings, as written.13

  • Risks Related to our Business Generally
  • Our growth plan contemplates our ability to create a Brokerage and Financial Markets business; however, this has been delayed for several years and may be difficult to achieve as our platform for expansion is a start-up business in the early stages of its development.
  • Our business remains heavily impacted by interested party transactions with certain of our officers and directors.
  • We might fail to realize the expected benefits and strategic objectives of our 2021 acquisition of a proprietary trading platform from a business affiliated with two members of the Company’s Board of Directors.
  • Substantially all of our employees are employed by professional employer organizations.
  • Unfavorable publicity associated with our now-concluded SEC inquiry.
  • Cyber-attacks may disrupt our operations and expose us to significant liability.
  • We may accept, disburse, and hold cryptocurrency, which may subject us to exchange risk and additional tax and regulatory requirements.
  • We may not be able to fully protect our proprietary rights, and we may infringe upon the proprietary rights of others, which could result in costly litigation.
  • Risks Related to our Conectiv Direct-to-Consumer Marketing Business
  • We may encounter risks relating to security or other system disruptions and failures that could reduce the attractiveness of our websites, and that could harm our business and results of operations.
  • We will need to introduce new products and services and enhance existing products and services to remain competitive.
The other 47 risks
  • We rely on external service providers to perform certain key functions.
  • We could face liability and other costs relating to storage and use of personal information about our users.
  • Our business could be negatively affected if we are required to defend allegations of unfair competition or unfair, false, or deceptive acts or practices in or affecting commerce.
  • The Polish Office of Competition and Consumer Protection (“UOKiK”) imposes a substantial fine and a cease-and-desist order, finding that the Company’s direct selling unit violated Polish laws that prohibit pyramid-style promotional schemes.
  • We have recently had to settle claims from Canadian Securities regulators that our direct selling business unit engaged in unlicensed regulated securities activities. Our business could be negatively affected if we are required to defend similar allegations from securities regulators in the United States or in other foreign countries in which we do business.
  • Our independent distributors could fail to comply with applicable legal requirements or our distributor policies and procedures, which could result in claims against us that could harm our business.
  • Our proprietary systems may be compromised by hackers.
  • Our business could be negatively affected if any of the third-party providers of products or services offered through our membership packages default on their obligation to our members.
  • Risks Related to our Blockchain Technology and Crypto Mining Products and Services
  • Our business could be negatively affected by claims related to a financial product underwritten, administered, and managed by a third-party provider, Total Protection Plus.
  • Our success depends on external factors affecting the Bitcoin industry.
  • The further development and acceptance of digital asset networks and other digital assets, which represent a new and rapidly changing industry, are subject to a variety of factors that are difficult to evaluate. The slowing or stopping of the development or acceptance of digital asset systems may adversely affect an investment in us.
  • Our ability to achieve profitability is largely dependent on the price of Bitcoin, which has historically been volatile.
  • Transaction fees may decrease demand for Bitcoin and prevent expansion.
  • We operate in a highly competitive market, and if we fail to grow our hash rate in a cost-effective manner, we may be unable to compete.
  • Bitcoin is programmatically subject to “Halving,” meaning that the Bitcoin rewarded for solving a block will be reduced in the future and its value may not commensurately adjust to compensate us for such reductions.
  • We are subject to risks associated with our need for significant electrical power, with that risk heightened as we are currently supplied with electrical power by a sole source provider.
  • Climate change and the regulatory and legislative developments related to climate change may materially adversely affect our business and financial condition.
  • Changing environmental regulations and public energy policy may expose our business to new risks.
  • The compliance costs of responding to new and changing regulations could adversely affect our operations.
  • Regulatory changes or actions may alter the nature of an investment in us or restrict the use of cryptocurrencies in a manner that adversely affects our business, prospects, or operations.
  • Our interactions with a blockchain may expose us to SDN or blocked persons, and new legislation or regulation could adversely impact our business or the market for cryptocurrencies.
  • Bitcoin and Bitcoin mining, as well as cryptocurrencies generally, may be made illegal in certain jurisdictions, including the ones we operate in, which could adversely affect our business prospects and operations.
  • The costs associated with our Bitcoin mining operations could be subject to a significant increase in the future should there occur an increase in the VAT tax imposed on our hosting services.
  • Risks Related to Our Health, Beauty, and Wellness Business
  • We have a limited history in the health, beauty, and wellness industry upon which you can evaluate our business and prospects.
  • Our products are subject to government regulation, both in the US and abroad, which could increase our costs significantly and limit or prevent the sale of our products.
  • If we experience product recalls, we may incur significant and unexpected costs, and our business reputation could be adversely affected.
  • We may experience product liability claims and litigation to prosecute such claims, and although we maintain product liability insurance, which we believe to be adequate for our needs, there can be no assurance that our insurance coverage will be adequate or that we will be able to maintain adequate insurance coverage.
  • Disruption in our supply chain and changes to tax or trade policy could have a negative impact on our business.
  • Risks Related to Our Common Stock
  • We may need to raise additional capital to execute on our growth plan. If we are unable to raise additional capital, our business may fail.
  • Our recent settlement with the SEC may limit our ability to access private financing.
  • Our common stock price has been and may continue to be extremely volatile.
  • Sales of substantial amounts of our common stock in the public markets or the perception that sales might occur could cause the trading price of our common stock to decline.
  • Conversion of existing convertible notes purchased by DBR Capital and the conversion rights associated with any future notes that may be purchased by DBR Capital could cause additional substantial dilution to our stockholders.
  • Special Governance Rights included within DBR Capital’s investments enable DBR Capital to retain significant control of the Company for the foreseeable future.
  • The trading price of shares of our common stock may increase or decrease as does the trading price of Bitcoin and other digital currencies, which subject investors to pricing risks, including “bubble” type risks, and volatility.
  • Conversion of exchangeable shares issued in connection with the acquisition of the assets of MPower.
  • Additional issuances of stock options and warrants, convertible notes, and stock grants will cause additional substantial dilution to our stockholders.
  • Shares of our common stock may never become eligible for trading on Nasdaq or a national securities exchange: we do not have a majority of independent directors.
  • If we fail to file periodic reports with the U.S. Securities and Exchange Commission, our common stock will not be able to be traded on the OTCQB.
  • Because we have no plans to pay dividends on our common stock, stockholders must look solely to the appreciation of our common stock to realize a gain on their investments.
  • Certain provisions of Nevada law and of our governing documents may inhibit a potential acquisition of our company, and this could have a negative impact on our stock price.
  • Our indemnification of our directors and officers may limit the rights of our stockholders.
  • We may be caused to issue a substantial number of shares of our common stock to our former Chief Executive Officer if our attempts to retire his note in cash are unsuccessful.
  • The amount of authorized common stock may result in management implementing anti-takeover procedures by issuing new securities.
  • Our stockholders may not recoup all or any portion of their investment upon our dissolution.
  • If we are required to register as an investment company under the Investment Company Act, the additional expenses and operational limitations associated with such registration may reduce our stockholders’ investment return or impair our ability to conduct our business as planned.
  • Our recent investments expose us to a concentration of assets, which could increase volatility, investment and market risk.

Legal proceedings

The Company is involved in various claims and legal actions arising in the ordinary course of business. In many claims and actions, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss. Accordingly, an adverse outcome from such proceedings could have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity. Legal expenses are expensed as incurred. A summary of potential material proceedings and litigation is as follows.

None of our directors, officers, or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

iGenius LLC v. Chairman of the Office of Competition, Competition and Consumer Protection Office, District Court in Warsaw, 17th Division for Competition and Consumer Protection (Court of Competition and Consumer Protection)

During February 2026, we filed an appeal to the December 2025 formal administrative decision of UOKiK in which it imposed an administrative fine of PLN 14,668,589 (approximately USD $4 million) on the Company and further seeks to require us to cease and desist the Company’s direct selling business operations in Poland. In its December 2025 decision, UOKiK determined that certain aspects of our direct selling business model, as conducted in Poland, violate Polish laws relating to unfair commercial practices, including laws prohibiting pyramid-style promotional schemes. Under the terms of the decision, enforcement of the fine and cease and desist components thereof, are not final and is subject to conclusion of any appeal to the competent Polish court.

The opening of Item 3, Legal Proceedings.13

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
    SEC EDGAROther events
  38. 38
    SEC EDGAROther events
  39. 39
    SEC EDGAROther events
  40. 40
    SEC EDGAROther events
  41. 41
  42. 42
    SEC EDGAROther events
  43. 43
    SEC EDGAROther events
  44. 44
    SEC EDGAROther events
  45. 45
  46. 46
  47. 47
  48. 48